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Pannexin1 channels dominate 
ATP release in the cochlea 
ensuring endocochlear potential 
and auditory receptor potential 
generation and hearing
Jin Chen1,2,*, Yan Zhu1,*, Chun Liang1,*, Jing Chen1 & Hong-Bo Zhao1
Pannexin1 (Panx1) is a gap junction gene in vertebrates whose proteins mainly function as non-
junctional channels on the cell surface. Panx1 channels can release ATP under physiological 
conditions and play critical roles in many physiological and pathological processes. Here, we report 
that Panx1 deficiency can reduce ATP release and endocochlear potential (EP) generation in the 
cochlea inducing hearing loss. Panx1 extensively expresses in the cochlea, including the cochlear 
lateral wall. We found that deletion of Panx1 in the cochlear lateral wall almost abolished ATP release 
under physiological conditions. Positive EP is a driving force for current through hair cells to produce 
auditory receptor potential. EP generation requires ATP. In the Panx1 deficient mice, EP and auditory 
receptor potential as measured by cochlear microphonics (CM) were significantly reduced. However, 
no apparent hair cell loss was detected. Moreover, defect of connexin hemichannels by deletion of 
connexin26 (Cx26) and Cx30, which are predominant connexin isoforms in the cochlea, did not reduce 
ATP release under physiological conditions. These data demonstrate that Panx1 channels dominate 
ATP release in the cochlea ensuring EP and auditory receptor potential generation and hearing. 
Panx1 deficiency can reduce ATP release and EP generation causing hearing loss.
Pannexins and connexins belong to gap junction gene families in vertebrates. However, they have com-
pletely different sequences1,2. Pannexins are homologous to innexins, which encode the gap junction 
proteins in invertebrates2. So far, three pannexin isoforms (Panx1, 2, and 3) have been cloned from 
the human and mouse genomes2. The profile of pannexin channel permeability is similar to that of 
connexin channels, which allow passage of ions and small molecules up to 1.5 kDa. However, unlike 
connexins, pannexins usually form non-junctional membrane channels on the cell surface to provide 
an intracellular-extracellular conduit3–6. Moreover, pannexin channels, particularly Panx1 channels, can 
open and function at physiological extracellular Ca++ levels, at which connexin channels are closed7. 
Panx1 channels can also be activated by mechanical stress, low oxygen, glutamate through NMDA recep-
tors, elevation of extracellular K+ concentrations, and ATP binding to purinergic receptors3,8–13. These 
specific properties imply that pannexin channels can function in a wider range of physiological condi-
tions.
Pannexins have ubiquitous cellular expression in many tissues and organs, including the inner ear. All 
three pannexin isoforms are expressed in the mammalian inner ear14. Panx1 expresses at the cochlear 
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supporting cells, the spiral limbus, and the cochlear lateral wall. Panx2 only expresses at the basal cell 
layer in the stria vascularis, and Panx3 expression is restricted to the cochlear bone. These distinct dis-
tribution patterns suggest that pannexins play important roles in the inner ear. However, the function of 
pannexin in the cochlea and hearing has not been characterized yet and remains unclear.
It has been reported that Panx1 channels can release ATP under physiological and pathological condi-
tions3,8,10,15,16 and play critical roles in many cellular and pathological processes, such as Ca++ homeosta-
sis, immunological responses, cell apoptosis, migraine, ischemia, and some neurological disorders9,17–24. 
ATP also plays important functions in the cochlea and hearing. It has been reported that ATP can elevate 
intracellular Ca++ concentration in hair cells to modify neurotransmission and extend the dynamic range 
of hearing25–28. We also found that ATP can mediate outer hair cell (OHC) electromotility to regulate 
hearing sensitivity, gap junctional coupling between the cochlear supporting cells, and K+-recycling29–32.
ATP is also required for generation of positive endocochlear potential (EP, + 100–110 mV)33–36. 
Positive EP is generated in the cochlear lateral wall33,36 and is a driving force that compels K+ ions in the 
endolymph through the transduction channels at stereocilia of hair cells to produce auditory receptor 
current and potential, thereby initiating hearing. In this study, we found that deletion of Panx1 in the 
cochlear lateral wall reduced ATP release and EP generation and thereby reduced auditory receptor 
potential leading to hearing loss. This indicates that Panx1 is required for EP generation and hearing.
Results
Panx1 deletion in the cochlea in Panx1 cKO mice. As we previously reported14, Panx1 had exten-
sive expression in the cochlea, including the spiral limbus, the organ of Corti, and the cochlear lateral 
wall (Fig.  1a,b). In Panx1 conditional knockout (cKO) mice, Panx1 expression at the organ of Corti 
Figure 1. Panx1 deletion in the cochlea in Panx1 conditional knockout (cKO) mice. a-b: 
Immunofluorescent staining for Panx1 in the WT mouse cochlea. c-d: Immunofluorescent staining for 
Panx1 in the Panx1 cKO mouse cochlea. An asterisk indicates that the area of type II fibrocytes in the 
cochlear lateral wall has no Panx1 labeling. OC: the organ of Corti, OS: outer sulcus cell, SLM: spiral limbus, 
SPL: spiral ligament. Scale bars: 25 μ m.
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and the spiral limbus remained. Immunofluorescent staining showed that intense labeling for Panx1 
was retained in these regions (Fig. 1c). However, Panx1 labeling at the cochlear lateral wall was absent 
(Fig. 1d). At the lateral wall of WT mouse cochlea, Panx1 was found to be mainly expressed at the type 
II fibrocytes in the spiral ligament (SPL) (Fig.  1b). In Panx1 cKO mice, Panx1 labeling at the type II 
fibrocytes was completely absent (indicated by an asterisk in Fig. 1d).
Deletion of Panx1 did not affect connexin expression. Cx26 and Cx30 are predominant connexin 
isoforms in the cochlea37–39. In Panx1 cKO mice, Cx26 and Cx30 expression at the cochlear lateral wall 
appeared normal (supplementary Fig. S2). There were no significant differences in Cx26 and Cx30 
expression at the cochlear lateral wall between Panx1 cKO mice and WT mice (Cx26: P = 0.38, Cx30: 
P = 0.13, one-way ANOVA).
Hearing loss in Panx1 cKO mice. Panx1 cKO mice had hearing loss (Fig.  2). The thresholds of 
auditory brainstem response (ABR) in Panx1 cKO mice at 8, 16, 24, 32, and 40 kHz were 64.7 ± 2.11, 
60.6 ± 2.77, 68.3 ± 3.45, 84.2 ± 2.19, and 92.2 ± 1.41 dB SPL, respectively (Fig. 2b). In comparison with 
wild-type (WT) mice, the ABR thresholds in Panx1 cKO mice at 8, 16, 24, 32, and 40 kHz were ele-
vated by 19.7 ± 2.11, 26.1 ± 2.77, 28.3 ± 3.45, 37.7 ± 2.19, and 43.2 ± 1.41 dB SPL, respectively (P < 0.001, 
one-way ANOVA with a Bonferroni correction). The hearing loss appeared severe at higher frequencies.
Figure 2. Hearing loss in Panx1 cKO mice . a: ABR waveforms recorded from Panx1 cKO and wild-
type (WT) mice. b: ABR thresholds were measured at age P40-60. **P < 0.001, one-way ANOVA with a 
Bonferroni correction.
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EP reduction in Panx1 cKO mice. The cochlear lateral wall is responsible for generation of positive 
EP. Fig. 3 shows that deletion of Panx1 at the cochlear lateral wall reduced EP. EP in Panx1 cKO mice and 
WT mice was 57.6 ± 6.03 and 98.2 ± 1.41 mV, respectively (Fig. 3b). In comparison with WT mice, the 
EP in Panx1 cKO mice was significantly reduced by 40% (P < 0.001, t-test). However, deletion of Panx1 
did not affect the lateral wall development. The thickness of the cochlear lateral wall in Panx1 cKO mice 
was similar to that in WT mice (P = 0.49, one-way ANOVA, supplementary Fig. S3).
Reduction of auditory receptor potential in Panx1 cKO mice. EP is the driving force for gen-
eration of auditory receptor current and potential. Fig.  4 shows that the auditory receptor potential as 
measured by cochlear microphonic (CM) in Panx1 cKO mice was reduced. In WT mice, the magnitudes 
of the recorded CM were 600–700 μ V and had a slight increase at 26 kHz near the recording place. In 
Panx1 cKO mice, the magnitudes of the recorded CM were ~250 μ V and significantly reduced by 60–70% 
(P < 0.001, one-way ANOVA with a Bonferroni correction) as compared with WT mice (Fig. 4b).
No apparent hair cell degeneration in Panx1 cKO mice. Fig. 5 shows that there was no apparent 
hair cell loss in Panx1 cKO mice. At the end of the basal turn (very high frequency region), Panx1 cKO 
mice had a significant increase in hair cell loss as compared with WT mice (P = 0.022, one-way ANOVA 
with a Bonferroni correction). However, the loss of hair cells was less than 10% (Fig. 5e), and could not 
produce broad, severe hearing loss as shown in Fig. 2.
Reduction of ATP release in Panx1 cKO mice. EP generation requires ATP34,35. Fig. 6 shows that 
deletion of Panx1 at the cochlear lateral wall almost abolished ATP release under physiological condi-
tions. At 2 mM extracellular Ca++ concentration, the amount of ATP release in Panx1 cKO and WT mice 
was 1.28 ± 0.23 and 10.58 ± 0.42 fmoles, respectively (Fig. 6a). Compared to WT mice, ATP release in 
Panx1 cKO mice was significantly reduced by ~8-fold (P < 0.001, one-way ANOVA with a Bonferroni 
correction). Moreover, application of carbenoxolone (CBX), which can block pannexin channels7, could 
also reduce ATP release in WT mice (Fig.  6a). The amount of ATP release under 0.1 mM CBX treat-
ment in the WT mice was significantly reduced to 1.71 ± 0.41 fmoles (P < 0.001, one-way ANOVA with 
a Bonferroni correction), similar to values obtained in Panx1 cKO mice. However, deletion of Cx26 or 
Cx30 did not reduce ATP release under the physiological level of Ca++ concentration (Fig.  6b). The 
measured ATP release at 2 mM extracellular Ca++ concentration in Cx26 KO mice and Cx30 KO mice 
was 10.87 ± 0.32 and 10.21 ± 0.41 fmoles, respectively. There was no significant difference in the amount 
of ATP released from WT and Cx26 KO mice or Cx30 KO mice (P = 0.98, one-way ANOVA).
Discussion
In this study, we found that Panx1 deficiency can cause hearing loss (Figs. 1 and 2). Deletion of Panx1 at 
the cochlear lateral wall abolished ATP release, reduced EP and auditory receptor potential generation, 
and eventually led to hearing loss (Figs.  3,4,6). These data reveal that Panx1 channel-mediated ATP 
release is required for EP generation and auditory receptor potential producing. This study also provides 
the first evidence that Panx1 is required for hearing.
Positive EP (+ 100-110 mV) in the cochlear endolymph is a driving force that propels K+ ions through 
transduction channels in hair cells to produce auditory receptor current and potential. Positive EP is gen-
erated in the cochlear lateral wall by a complex process33,36. Based on a widely accepted “two-cell” model 
(Fig. 7), EP generation is initiated at fibrocyte cells in the spiral ligament. Na+/K+-ATPases and Na+, K+, 
Figure 3. Reduction of EP in Panx1 cKO mice. a: Time-sequence of DC potential changes in electrode 
penetrating through the cochlear lateral wall. b: EP reduction in Panx1 cKO mice. EP was recorded at age 
P40-60. ** P < 0.001, t-test.
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2Cl- cotransporters at the type II fibrocyte cells depolarize cells to ~ –5 mV. Then, the intermediate cells in 
the stria vascularis (SV) are consequently depolarized to ~ –5 mV through gap junctional coupling, which 
is formed by Cx26 and Cx3039. Subsequently, ATP-dependent Kir4.1 K+ channels at the apical membrane 
of the intermediate cells 39–41 generate a 105-110 mV transmembrane potential (Nernst’s K+ equilibrium 
potential) between the intracellular space and the intrastrial space, i.e., + 110-115 mV in the intrastrial 
space with respect to normal extracellular space, since the K+ concentration in the intrastrial space is 
lower (1-2 mM). Finally, this positive intrastrial potential eventually leads to positive EP (+ 100-110 mV) 
in the endolymph in the scala media (Fig. 7).
Evidently, ATP is necessary and required for EP generation. It has been reported that intracochlear 
perfusion of ATP can significantly increase EP42. As mentioned above, depolarization of fibrocyte cells by 
co-activation of Na+/K+-ATPases and Na+, K+, 2Cl– -cotransporters is the first step for EP generation. 
Although Na+/K+-ATPase is driven by intracellular ATP, it has been reported that extracellular ATP can 
also stimulate Na+/K+-ATPase activity through activation of purinergic receptors and Src family kinase 
(SFK)43. Moreover, the function of the primary active Na+/K+-ATPase requires K channel coupling to 
recycle K+ (Fig.  7b). This “pump coupling” was postulated in 1958 and later corroborated by experi-
mental data44–46. Recently, it has been found that extracellular ATP can also activate ATP-sensitive (Kir) 
K channels in hippocampal CA3 pyramidal neurons and lung epithelial cells to co-operate with Na+/
K+-ATPases activity47,48. ATP may primarily activate P2X receptors and then subsequently activate Kir 
K channels and Na+/K+-ATPases (Fig.  7b). In this study, we found that Panx1 deletion reduced ATP 
release and EP (Figs. 3and 6). These findings indicate that Panx1 channel-mediated ATP release plays an 
important role in the EP generation. We previously also found that ATP is required for K+-recycling in 
the cochlea31,32. Deletion of Panx1 reduced ATP release (Fig. 6) and could also consequently compromise 
K+-recycling to impair EP generation (Fig. 7a).
In this study, we found that deletion of Panx1 or application CBX in WT mice abolished ATP release 
in the cochlear lateral wall at physiological extracellular Ca++ (2 mM) levels (Fig. 6). CBX can block both 
connexin and pannexin channels7,13. However, the connexin hemichannels are already closed at this high 
Ca++ level7. Thus, CBX in this experiment mainly blocked Panx1 channel activity. These data indicate 
that Panx1 channels dominate ATP release in the cochlear lateral wall under physiological conditions, 
even thought other ATP release mechanisms may exist. This concept is further supported by the fact 
that Cx26 or Cx30 deletion did not reduce ATP release at 2 mM physiological extracellular Ca++ level 
(Fig. 6b), at which concentration connexin  hemichannels are closed7. Thus, deletion of Cx26 or Cx30 
had little effect on ATP release under physiological conditions (Fig.  6b). Cx26 or Cx30 deletion could 
also reduce or abolish EP. However, the EP reduction results from the disruption of gap junctional cou-
pling49,50.
Gap junctions play an important role in hearing. Connexin mutations can induce a high incidence of 
hearing loss, responsible for >50% of nonsyndromic deafness51. However, pannexin mutation-induced 
hearing loss in humans has not been identified yet. In this study, we found that Panx1 deficiency could 
cause hearing loss in mice (Fig. 2). This strongly suggests that Panx1 deficiency may be able to induce 
hearing loss in humans as well, which requires further study in the future.
Materials and Methods
Creation of Panx1 cKO mice and genotyping. Panx1tm1a(KOMP)Wtsi mice, in which Exon2 is floxed 
with loxPs (supplementary Fig. S1a), were purchased from KOMP (Knock Out Mouse Project, David, 
Figure 4. CM reduction in Panx1 cKO mice. Mice were P40-60 old. a: The recorded CM waveforms from 
WT and Panx1 cKO mice. b: CM reduction in Panx1 cKO mice. ** P < 0.001, one-way ANOVA with a 
Bonferroni correction.
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CA). They have a hypomorphic phenotype52 and retain Panx1 expression in the cochlea (supplementary 
Fig. S4). We further crossed Panx1tm1a(KOMP)Wtsi mice with Foxg1-Cre transgenic mice (Stock No. 004337, 
Jackson Lab, http://jaxmice.jax.org/strain/004337.html) to create Panx1 cKO mice. The genotyping of 
Panx1tm1a(KOMP)Wtsi mice was identified by PCR amplification with the following primers: Panx1-Mut1 
(common mutant primer): 5’-GAG ATG GCG CAA CGC AAT TAA T-3’, Panx1-Mut2 (gene specific 
primer): 5’-CTG GCT CTC ATA ATT CTT GCC CTG-3’, Panx1-WF (wildtype-F): 5’-CTG TAT CAC 
ACA ACC ACT TCA GAG AAG G-3’, and Panx1-WR (wildtype-R): 5’-GAG CTG ACC CCT TTC CAT 
TCA ATA G-3’, and generated a 579 bp WT band and a 381 bp mutation band (supplementary Fig. S1b). 
The Cre transgene in the generated Panx1-Foxg1 mice was identified using following primers: CreF: 
5’-GCA TTA CCG GTC GAT GCA-3’ and CreR: 5’-GAA CCT GGTCGA AAT CAG-3’, which produced 
~400 bp positive band for the Cre transgene (Fig. S1c). The post-Cre Exon2-deleted Panx1 allele in 
Panx1-Foxg1 mice was identified by Panx1-Mut1a (post-Cre mutant primer): 5’-CAC TGC ATT CTA 
GTT GTG GTT TGT CC-3’ and Panx1-Mut2 (gene specific primer): 5’-CTG GCT CTC ATA ATT CTT 
GCC CTG-3’, which generated a 421 bp band after deletion of Exon2. The reaction would be negative 
for WT or no Exon2 deletion (supplementary Fig. S1d). We used homozygous Foxg1Cre:Panx1f/f mice as 
Panx1 cKO mice in this study. The WT littermate mice served as WT controls in the experiment. The 
experimental procedures were approved by the University of Kentucky’s Animal Care & Use Committee 
and conducted according to the standards of the NIH Guidelines for the Care and Use of Laboratory 
Animals.
Cx26 KO and Cx30 KO mice. As we previously reported53, Cx26 KO mice were generated by cross-
ing Cx26loxP/loxP mice (EM00245, European Mouse Mutant Archive) with the Pax2-Cre mouse line (the 
Mutation Mouse Regional Center, Chapel Hill, NC). The Cx26 floxed allele and Pax2-Cre transgene were 
detected on tail genomic DNA by PCR amplification using the following primers: Cx26F: 5’-CTT TCC 
AAT GCT GGT GGA GTG-3’ and Cx26R: 5’-ACA GAA ATG TGT TGG TGA TGG-3’ for the Cx26 
floxed allele; Pax2-CreF: 5’-GCC TGC ATT ACC GGT CGA TGC AAC GA- 3’ and Pax2-CreR: 5’-GTG 
GCA GAT GGC GCG GCA ACA CCA TT- 3’ for Pax2-Cre transgene. Cx26loxP/loxP and WT mice gen-
erated 400 and 300 bps bands, respectively. The band of Pax2-Cre was 700 bps.
Cx30 KO mice were also purchased from European Mouse Mutant Archive (EM0032349,50, ). Primer 
pairs for detecting Cx30 KO were Cx30 KO-1 (LACZ e Neo): 5’-GGT ACC TTC TAC TAA TTA GCT 
TGG -3’; Cx30 KO2 (LACZ e Neo): 5’-AGG TGG TAC CCA TTG TAG AGG AAG -3’; Cx30 KO-3 
(LACZ e Neo) 5’-AGC GAG TAA CAA CCC GTC GGA TTC -3’. The bands of Cx30 KO and WT mice 
are located at 460 and 544 bps, respectively.
ABR measurement. ABR was measured by a Tucker-Davis’ ABR workstation (Tucker-Davis Tech. 
Alachua, FL)50,53–55. Mice were anaesthetized by intraperitoneal injection with a mixture of ketamine and 
xylazine (8.5 ml saline + 1 ml Ketamine + 0.55 ml Xylazine, 0.1 ml per 10 g). Body temperature was main-
tained at 37–38 oC. Two subdermal needle electrodes were inserted at the vertex (an active electrode) and 
ventrolaterally to the right or left ear (a reference electrode). The ground needle electrode was inserted 
in the right leg. ABR was measured by clicks in alternative polarity and series tone bursts (8 – 40 kHz) 
Figure 5. No substantial hair cell degeneration in Panx1 cKO mice. a-c: The cochlear sensory epithelia 
of Panx1 cKO mice staining with phalloidin-Alexa Fluor-488 (green) and propidium iodide (PI, red). White 
arrows in panel c indicate scattered loss of outer hair cells (OHCs) in the basal turn. Scale bars: 50 μ m.  
d: A high-magnification image. Inner hair cell’s (IHC) and OHC’s hair bundles are clearly visible. Scale bars: 
20 μ m. e: Hair cell loss accounting in Panx1 cKO and WT mice. Mice were P60-90 old. * P < 0.05, one-way 
ANOVA with a Bonferroni correction.
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from 80 to 10 dB SPL in a 5-dB step. The ABR threshold was determined by the lowest level at which 
an ABR can be recognized. If the ABR threshold was greater than 75 dB SPL, the acoustic stimuli from 
110 to 70 dB SPL were added.
EP and CM recording. Mice were anaesthetized as described above and the body temperature was 
maintained at 37–38 oC. The trachea was exposed and cut along the middle line. The tracheal tube was 
put into the trachea. Then, the cochlea was exposed by a ventral approach and the bone over the spiral 
ligament was gently picked to form a small hole50,54,55. A glass pipette filled with a K+-based intracellular 
solution was inserted into the hole. The DC potential was continually recorded as the electrode pipette 
penetrated through the lateral wall (Fig. 3a).
For CM recording, acoustic tone bursts (3.25 – 52 kHz) were delivered through an ES-1 high fre-
quency speaker (Tucker Davis Tech. FL). The CM response was recorded by MultiClamp 700A amplifier 
(Molecular Devices, CA) and digitized utilizing a Digidata 1322A (Molecular Devices, CA).
ATP release measurement. As we previously reported29, the mouse temporal bone was 
micro-dissected in a sterile normal extracellular solution (ECS) (142 NaCl, 5.37 KCl, 1.47 MgCl2, 2 
CaCl2, 10 HEPES in mM, osmolarity 310 mOsm and pH 7.2). The inner ear was opened from its apex 
to base. After removal of the bone, the exposed cochlear lateral wall was dissected and put into an incu-
bation chamber. For testing Panx1 channel ATP release, the isolated lateral wall was incubated in 200 μ L 
ECS, which contains 2 mM Ca++ and 1.47 mM Mg++ to block connexin hemichannels, for 10 minutes. 
Every 5 minutes, the whole incubation solution (200 μ L) was collected and replaced with fresh solution. 
The osmolarity of all solutions was measured by a micro-computer controlled osmometer (Model 3300, 
Advanced Instruments Inc. Norwood, MA) and adjusted by Dextrose. All experiments were performed 
at room temperature (23 oC).
The collected incubation solutions were kept on ice. As we previously reported29, the amount of ATP 
was measured by a bioluminescence method with a luciferin-luciferase assay kit (FL-ASC, Sigma) using 
a black 96-well plate to avoid optical cross-talk. The bioluminescence was read by a Biotek Synergy 4 
Hybrid Microplate Reader (Biotek Instruments Inc, Winooski, VT, USA). The amount of ATP was cal-
culated from the ATP standard curve, which was established from measurements of serial-diluted ATP 
standards (supplementary Fig. S5). The standard curve also served as an internal control for biolumi-
nescence measurement.
Immunofluorescent staining and quantitative measurement. The detailed methods and proce-
dures of immunofluorescent staining can be found in our previous reports14,38,39. The cochlea was fixed 
with 4% paraformaldehyde. The cochlear cryostat sections were washed with PBS for 5 min twice and 
incubated in a blocking solution (10% goat serum and 1% bovine serum albumin) with 0.1% Triton X-100 
for 30 min. Then, the tissue sections were incubated with chicken anti-human Panx1 antibody (1:500; 
#4515, a gift from Dr. Gerhard Dahl at the University of Miami Medical School) in the blocking solution 
overnight. For double immunofluorescent staining, monoclonal mouse anti-Cx26 antibody (1: 400, Cat# 
33-5800, Invitrogen, CA) and polyclonal rabbit anti-Cx30 antibody (1:400, #71-2200, Invitrogen, CA) 
were used. After being washed with PBS three times, the sections were reacted with corresponding Alexa 
Fluor 488- or 568 secondary antibodies (1:500, Molecular Probes) for 2 hr at room temperature (23 oC). 
Figure 6. Reduction of ATP release in the cochlea in Panx1 cKO mice. Mice were P40-60 old. a: ATP 
release is reduced in Panx1 cKO mice and inhibited by application of 0.1 mM CBX. **P < 0.001, one-way 
ANOVA with a Bonferroni correction. b: Connexin deletion does not reduce ATP release in the cochlea.
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The staining was observed under a fluorescent microscope or laser confocal microscope. The images were 
saved in TIFF format for analysis and presentation.
For quantitative measurement of Cx26 and C30 labeling at the cochlear lateral wall, ImageJ software 
(NIH, Bethesda, MD) was used38,55. The density of labeling at the lateral wall was measured and com-
pared between WT and Panx1 cKO mice.
Statistical analysis. Data were expressed as mean ± s.e.m. unless otherwise indicated in text and 
plotted by SigmaPlot (SPSS Inc. Chicago, IL). The statistical analyses were performed by SPSS v18.0 
(SPSS Inc. Chicago, IL) using one-way ANOVA with a Bonferroni correction or t-test.
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